Genome-scale CRISPR-Cas9 knockout screening in human cells

Shalem, Ophir, Sanjana, Neville E., Hartenian, Ella, Shi, Xi, Scott, David A., Mikkelsen, Tarjei S., Heckl, Dirk, Ebert, Benjamin L. +3 more·2014·Science
DOI 10.1126/science.1247005

Cited by (1,041)

Items 201–300 of 1,041

  1. CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
    Han, Kyuho, Pierce, Sarah E., Li, Amy, Spees, Kaitlyn, Anderson, Gray R., Seoane, Jose A., Lo, Yuan-Hung, Dubreuil, Michael, Olivas, Micah, Kamber, Roarke A. et al. · 2020 · Nature
  2. Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
    Muir, Alexander, Danai, Laura V, Gui, Dan Y, Waingarten, Chiara Y, Lewis, Caroline A, Vander Heiden, Matthew G · 2017 · eLife
  3. A new era in functional genomics screens
    Przybyla, Laralynne, Gilbert, Luke A. · 2022 · Nature Reviews Genetics
  4. Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells
    Martina Bajzíková, Jaromíra Kovářová, Ana Raquel Coelho, Štěpána Boukalová, Sehyun Oh, Kateřina Rohlenová, Dávid Švec, Soňa Hubáčková, Berwini Endaya, Kristýna Judasová et al. · 2018 · Cell Metabolism
  5. Genome-wide Targeted Mutagenesis in Rice Using the CRISPR/Cas9 System
    Yuming Lu, Xiao Ye, Renming Guo, Jing Huang, Wei Wang, Jiuyou Tang, Longtao Tan, Jian‐Kang Zhu, Chengcai Chu, Yangwen Qian · 2017 · Molecular Plant
  6. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
    Helena J. Janse van Rensburg, Taha Azad, Min Ling, Yawei Hao, Brooke Snetsinger, Prem Khanal, Lori M. Minassian, Charles H. Graham, Michael J. Rauh, Xiaolong Yang · 2018 · Cancer Research
  7. Integrated cross-study datasets of genetic dependencies in cancer
    C. Pacini, Joshua M. Dempster, Isabella A. Boyle, E. Gonçalves, H. Najgebauer, E. Karakoç, D. van der Meer, Andrew S. Barthorpe, H. Lightfoot, P. Jaaks et al. · 2020 · Nature Communications
  8. CRISPR/Cas9-based engineering of the epigenome
    Pulecio, Julian, Verma, Nipun, Mejía-Ramírez, Eva, Huangfu, Danwei, Raya, Angel · 2017 · Cell Stem Cell
  9. Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures
    Ying Yan, Le Chang, Lunan Wang · 2020 · Reviews in Medical Virology
  10. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
    Yunkai Zhu, Fei Feng, Gaowei Hu, Yuyan Wang, Yu Yin, Yuanfei Zhu, Wei Xü, Xia Cai, Zhiping Sun, Wendong Han et al. · 2021 · Nature Communications
  11. CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
    Vyas Ramanan, Amir Shlomai, David B.T. Cox, Robert E. Schwartz, Eleftherios Michailidis, Ankit Bhatta, David A. Scott, Feng Zhang, Charles M. Rice, Sangeeta N. Bhatia · 2015 · Scientific Reports
  12. Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity
    Josh Tycko, Vic E. Myer, Patrick D. Hsu · 2016 · Molecular Cell
  13. Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair
    Tony Gutschner, Monika Hämmerle, Giannicola Genovese, Giulio Francesco Draetta, Lynda Chin · 2016 · Cell Reports
  14. Genome-wide CRISPR screens reveal a Wnt–FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors
    Zachary Steinhart, Zvezdan Pavlovic, Megha Chandrashekhar, Traver Hart, Xiaowei Wang, Xiaoyu Zhang, Mélanie Robitaille, Kevin R. Brown, Sridevi Jaksani, René Overmeer et al. · 2016 · Nature Medicine
  15. N-terminal degradation activates the NLRP1B inflammasome
    Ashley J. Chui, Marian C. Okondo, Sahana D. Rao, Kuo Gai, Andrew R. Griswold, Darren C. Johnson, Daniel P. Ball, Cornelius Y. Taabazuing, Elizabeth L. Orth-He, Brooke A. Vittimberga et al. · 2019 · Science
  16. Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications
    Maurice Labuhn, Felix F. Adams, Michelle Shu Wen Ng, Sabine Knoess, Axel Schambach, Emmanuelle Charpentier, Adrian Schwarzer, Juan Luis Mateo, Jan‐Henning Klusmann, Dirk Heckl · 2017 · Nucleic Acids Research
  17. Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease
    Edward M. Kennedy, Anand V. R. Kornepati, Michael Goldstein, Hal P. Bogerd, Brigid Chiyoko Poling, Adam W. Whisnant, Michael B. Kastan, Bryan R. Cullen · 2014 · Journal of Virology
  18. Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T-cell dysfunction
    Singh, Nathan, Lee, Yong Gu, Shestova, Olga, Ravikumar, Pranali, Hayer, Katharina E., Hong, Seok Jae, Lu, Xueqing Maggie, Pajarillo, Raymone, Agarwal, Sangya, Kuramitsu, Shunichiro et al. · 2020 · Cancer Discovery
  19. Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination
    Sivanand, Sharanya, Rhoades, Seth, Jiang, Qinqin, Lee, Joyce V., Benci, Joseph, Zhang, Jingwen, Yuan, Salina, Viney, Isabella, Zhao, Steven, Carrer, Alessandro et al. · 2017 · Molecular Cell
  20. Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning
    Arbab, Mandana, Shen, Max W., Mok, Beverly, Wilson, Christopher, Matuszek, Żaneta, Cassa, Christopher A., Liu, David R. · 2020 · Cell
  21. BAGEL: a computational framework for identifying essential genes from pooled library screens
    Traver Hart, Jason Moffat · 2016 · BMC Bioinformatics
  22. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
    Matthew Hackbart, Xufang Deng, Susan C. Baker · 2020 · Proceedings of the National Academy of Sciences
  23. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses
    Li, Yize, Banerjee, Shuvojit, Wang, Yuyan, Goldstein, Stephen A., Dong, Beihua, Gaughan, Christina, Silverman, Robert H., Weiss, Susan R. · 2016 · Proceedings of the National Academy of Sciences
  24. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
    Parolia, Abhijit, Cieslik, Marcin, Chu, Shih-Chun, Xiao, Lanbo, Ouchi, Takahiro, Zhang, Yuping, Wang, Xiaoju, Vats, Pankaj, Cao, Xuhong, Pitchiaya, Sethuramasundaram et al. · 2019 · Nature
  25. High-resolution interrogation of functional elements in the noncoding genome
    Neville E. Sanjana, Jason B. Wright, Kaijie Zheng, Ophir Shalem, Pierre Fontanillas, Julia Joung, Christine S. Cheng, Aviv Regev, Feng Zhang · 2016 · Science
  26. The nuclear export protein XPO1 — from biology to targeted therapy
    Asfar Sohail Azmi, Md. Hafiz Uddin, Ramzi M. Mohammad · 2020 · Nature Reviews Clinical Oncology
  27. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
    Adam David Durbin, Mark W. Zimmerman, Neekesh V. Dharia, Brian J. Abraham, Amanda Balboni Iniguez, Nina Weichert‐Leahey, Shuning He, John Michael Krill-Burger, David E. Root, Francisca Vázquez et al. · 2018 · Nature Genetics
  28. TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery
    Artem A. Nemudryi, Kamila R. Valetdinova, Sergey P. Medvedev, Suren M. Zakian · 2014 · Acta Naturae
  29. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B
    Liang Tao, Jie Zhang, Paul Meraner, Alessio Tovaglieri, Xiaoqian Wu, Ralf Gerhard, Xinjun Zhang, William B. Stallcup, Ji Miao, Xi He et al. · 2016 · Nature
  30. Genetics and epigenetics of eating disorders
    Bulik, Cynthia, Yilmaz, Zeynep, HArdaway, Andrew · 2015 · Advances in Genomics and Genetics
  31. Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
    Rinath M. Jeselsohn, Johann S. Bergholz, Matthew J Pun, MacIntosh Cornwell, Weihan Liu, Agostina Nardone, Tengfei Xiao, Wei Li, Xintao Qiu, Gilles Buchwalter et al. · 2018 · Cancer Cell
  32. Emerging and evolving concepts in gene essentiality
    Giulia Irene Rancati, Jason Moffat, Athanasios Typas, Norman Pavelka · 2017 · Nature Reviews Genetics
  33. Predicting the efficiency of prime editing guide RNAs in human cells
    Hui Kwon Kim, Goosang Yu, Jinman Park, Seonwoo Min, Sungtae Lee, Sungroh Yoon, Seokjoong Kim · 2020 · Nature Biotechnology
  34. Targeting Transcription Factors in Cancer
    Bhagwat, Anand S., Vakoc, Christopher R. · 2015 · Trends in Cancer
  35. Consequences of Cas9 cleavage in the chromosome of Escherichia coli
    Lun Cui, David Bikard · 2016 · Nucleic Acids Research
  36. Targeting of Photoreceptor Genes inChlamydomonas reinhardtiivia Zinc-Finger Nucleases and CRISPR/Cas9
    André Greiner, Simon Kelterborn, Heide Evers, Georg Kreimer, Irina A. Sizova, Peter Hegemann · 2017 · The Plant Cell
  37. Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease
    James E. Dahlman, Omar O. Abudayyeh, Julia Joung, Jonathan S. Gootenberg, Feng Zhang, Silvana Konermann · 2015 · Nature Biotechnology
  38. Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
    Gu, Shengqing Stan, Zhang, Wubing, Wang, Xiaoqing, Jiang, Peng, Traugh, Nicole, Li, Ziyi, Meyer, Clifford, Stewig, Blair, Xie, Yingtian, Bu, Xia et al. · 2021 · Cancer Discovery
  39. CRISPR-Cas9 for cancer therapy: Opportunities and challenges
    Chen, Minjiang, Mao, Aiwu, Xu, Min, Weng, Qiaoyou, Mao, Jianting, Ji, Jiansong · 2019 · Cancer Letters
  40. Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice
    Yu, Wenhan, Mookherjee, Suddhasil, Chaitankar, Vijender, Hiriyanna, Suja, Kim, Jung-Woong, Brooks, Matthew, Ataeijannati, Yasaman, Sun, Xun, Dong, Lijin, Li, Tiansen et al. · 2017 · Nature Communications
  41. Notum produced by Paneth cells attenuates regeneration of aged intestinal epithelium
    Pentinmikko, Nalle, Iqbal, Sharif, Mana, Miyeko, Andersson, Simon, Cognetta, Armand B., Suciu, Radu M., Roper, Jatin, Luopajärvi, Kalle, Markelin, Eino, Gopalakrishnan, Swetha et al. · 2019 · Nature
  42. Viral Delivery Systems for CRISPR
    Xu, Christine L., Ruan, Merry Z. C., Mahajan, Vinit B., Tsang, Stephen H. · 2019 · Viruses
  43. Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
    Vredevoogd, David W., Kuilman, Thomas, Ligtenberg, Maarten A., Boshuizen, Julia, Stecker, Kelly E., de Bruijn, Beaunelle, Krijgsman, Oscar, Huang, Xinyao, Kenski, Juliana C.N., Lacroix, Ruben et al. · 2019 · Cell
  44. Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1
    Michael Douglas Crowther, Garry M. Dolton, Mateusz Legut, Marine E. Caillaud, Angharad Lloyd, Meriem Attaf, Sarah A. E. Galloway, Cristina Rius, Colin P. Farrell, Barbara Szomolay et al. · 2020 · Nature Immunology
  45. N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2
    Yuan Li, Linjian Xia, Kaifen Tan, Xidong Ye, Zhixiang Zuo, Minchun Li, Rui Xiao, Zihan Wang, Xiaona Liu, Mingqiang Deng et al. · 2020 · Nature Genetics
  46. Genome modification by CRISPR /Cas9
    Yuanwu Ma, Lianfeng Zhang, Xingxu Huang · 2014 · FEBS Journal
  47. A Convergence-Based Framework for Cancer Drug Resistance
    Konieczkowski, David J., Johannessen, Cory M., Garraway, Levi A. · 2018 · Cancer Cell
  48. Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication
    Julianna Han, Jasmine T. Perez, Cindy Chen, Yan Li, Asiel Arturo Benitez, Matheswaran Kandasamy, Yoontae Lee, Jorge Andrade, Benjamin Robert tenOever, Balaji Manicassamy · 2018 · Cell Reports
  49. The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery
    Kevin Dzobo · 2021 · Elsevier eBooks
  50. Highly Efficient CRISPR-Cas9-Based Methods for Generating Deletion Mutations and F0 Embryos that Lack Gene Function in Zebrafish
    Kazuyuki Hoshijima, Michael J. Jurynec, Dana Klatt Shaw, Ashley M. Jacobi, Mark A. Behlke, David Jonah Grunwald · 2019 · Developmental Cell
  51. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency
    Giampazolias, Evangelos, Zunino, Barbara, Dhayade, Sandeep, Bock, Florian, Cloix, Catherine, Cao, Kai, Roca, Alba, Lopez, Jonathan, Ichim, Gabriel, Proïcs, Emma et al. · 2017 · Nature Cell Biology
  52. Sublethal cytochrome c release generates drug-tolerant persister cells
    Halime Kalkavan, Jinan Chen, Jeremy Chase Crawford, Giovanni Quarato, PATRICK J. FITZGERALD, Stephen W. G. Tait, Colin R. Goding, Douglas R. Green · 2022 · Cell
  53. Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer
    Bar-Peled, Liron, Kemper, Esther K., Suciu, Radu M., Vinogradova, Ekaterina V., Backus, Keriann M., Horning, Benjamin D., Paul, Thomas A., Ichu, Taka-Aki, Svensson, Robert U., Olucha, Jose et al. · 2017 · Cell
  54. Emerging roles for lipids in non-apoptotic cell death
    Leslie Magtanong, Pin‐Joe Ko, Scott J. Dixon · 2016 · Cell Death and Differentiation
  55. CRISPR/Cas9‐mediated genome engineering: An adeno‐associated viral (AAV) vector toolbox
    Elena Senís, Chronis Fatouros, Stefanie Große, Ellen Wiedtke, Dominik Niopek, Ann‐Kristin Mueller, Kathleen Börner, Dirk Grimm · 2014 · Biotechnology Journal
  56. Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality
    Alexandra E. Briner, Paul D. Donohoue, Ahmed A. Gomaa, Kurt Selle, Euan M. Slorach, Christopher H. Nye, R.E. Haurwitz, Chase L. Beisel, Andrew P. May, Rodolphe Barrangou · 2014 · Molecular Cell
  57. CRISPR technologies for genome, epigenome and transcriptome editing
    Lukas Villiger, Julia Joung, Luke W. Koblan, Jonathan S. Weissman, Omar O. Abudayyeh, Jonathan S. Gootenberg · 2024 · Nature Reviews Molecular Cell Biology
  58. An Efficient Genotyping Method for Genome-modified Animals and Human Cells Generated with CRISPR/Cas9 System
    Xiaoxiao Zhu, Yajie Xu, Shanshan Yu, Lu Lu, Mingqin Ding, Jing Cheng, Guoxu Song, Xing Gao, Liangming Yao, Dongdong Fan et al. · 2014 · Scientific Reports
  59. Structural basis of NINJ1-mediated plasma membrane rupture in cell death
    Morris Degen, José Carlos Santos, Kristýna Pluháčková, Gonzalo Cebrero, Saray Ramos, Gytis Jankevicius, Ella Hartenian, Undina Guillerm, Stefania Anna Mari, Bastian Kohl et al. · 2023 · Nature
  60. Multi‐input CRISPR/Cas genetic circuits that interface host regulatory networks
    Alec A. K. Nielsen, Christopher A. Voigt · 2014 · Molecular Systems Biology
  61. An Argonaute phosphorylation cycle promotes microRNA-mediated silencing
    Ryan J. Golden, Beibei Chen, Tuo Li, Juliane Braun, Hema Manjunath, Xiang Chen, Jiaxi Wu, Vanessa Schmid, Tsung-Cheng Chang, Florian B. Kopp et al. · 2017 · Nature
  62. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell
    Steven W. Plouffe, Kimberly C. Lin, Jerrell L. Moore, Frederick E. Tan, Shenghong Ma, Zhen Ye, Yunjiang Qiu, Bing Ren, Kun‐Liang Guan · 2018 · Journal of Biological Chemistry
  63. GuideScan software for improved single and paired CRISPR guide RNA design
    Alexendar R. Perez, Yuri Pritykin, Joana Alves Vidigal, Sagar Chhangawala, Lee Zamparo, Christina S. Leslie, Andrea Ventura · 2017 · Nature Biotechnology
  64. Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets
    Joshua M. Dempster, Clare Pacini, Sasha Pantel, Fiona M. Behan, Thomas Green, John Michael Krill-Burger, Charlotte Beaver, Scott T. Younger, Victor Zhivich, Hanna Najgebauer et al. · 2019 · Nature Communications
  65. A Pliable Mediator Acts as a Functional Rather Than an Architectural Bridge between Promoters and Enhancers
    El Khattabi, Laila, Zhao, Haiyan, Kalchschmidt, Jens, Young, Natalie, Jung, Seolkyoung, Van Blerkom, Peter, Kieffer-Kwon, Philippe, Kieffer-Kwon, Kyong-Rim, Park, Solji, Wang, Xiang et al. · 2019 · Cell
  66. High-content CRISPR screening
    Christoph Bock, Paul Datlinger, Florence M. Chardon, Matthew A. Coelho, Matthew B. Dong, Keith A. Lawson, Tian Lu, Laetitia Maroc, Thomas M. Norman, Bicna Song et al. · 2022 · Nature Reviews Methods Primers
  67. Functional Modules of the Proteostasis Network
    Gopal Gunanathan Jayaraj, Mark S. Hipp, F. Ulrich Hartl · 2019 · Cold Spring Harbor Perspectives in Biology
  68. Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease
    Zhu, Min, Lu, Tianshi, Jia, Yuemeng, Luo, Xin, Gopal, Purva, Li, Lin, Odewole, Mobolaji, Renteria, Veronica, Singal, Amit G., Jang, Younghoon et al. · 2019 · Cell
  69. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
    Huimin Zhang, Chunhong Qin, Changming An, Xiwang Zheng, Shuxin Wen, Wenjie Chen, Xianfang Liu, Zhenghua Lv, Ping–Chang Yang, Wei Xu et al. · 2021 · Molecular Cancer
  70. Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells
    Masahiro Okada, Shunsuke Chikuma, Taisuke Kondo, Sana Hibino, Hiroaki Machiyama, Tadashi Yokosuka, Miyako Nakano, Akihiko Yoshimura · 2017 · Cell Reports
  71. XPO1-dependent nuclear export as a target for cancer therapy
    Nancy G. Azizian, Yulin Li · 2020 · Journal of Hematology & Oncology
  72. To metabolomics and beyond: a technological portfolio to investigate cancer metabolism
    Federica Danzi, Raffaella Pacchiana, Andrea Mafficini, Maria Teresa Scupoli, Aldo Scarpa, Massimo Donadelli, Alessandra Fiore · 2023 · Signal Transduction and Targeted Therapy
  73. Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
    Murtuza, Ayesha, Bulbul, Ajaz, Shen, John Paul, Keshavarzian, Parissa, Woodward, Brian D., Lopez-Diaz, Fernando J., Lippman, Scott M., Husain, Hatim · 2019 · Cancer Research
  74. Review of CRISPR/Cas9 sgRNA Design Tools
    Yingbo Cui, Jiaming Xu, Minxia Cheng, Xiangke Liao, Shaoliang Peng · 2018 · Interdisciplinary Sciences Computational Life Sciences
  75. AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
    Ryan Dz-Wei Chow, Christopher D. Guzman, Guangchuan Wang, Florian Schmidt, Mark W. Youngblood, Lupeng Ye, Youssef Errami, Matthew B. Dong, Michael A. Q. Martinez, Sensen Zhang et al. · 2017 · Nature Neuroscience
  76. TP53 loss creates therapeutic vulnerability in colorectal cancer
    Yunhua Liu, Xinna Zhang, Cecil Han, Guohui Wan, Xingxu Huang, Cristina Ivan, Dahai Jiang, Cristian Rodriguez‐Aguayo, Gabriel Lopez‐Berestein, Pulivarthi H. Rao et al. · 2015 · Nature
  77. Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
    Alan S.L. Wong, Gigi C.G. Choi, Cheryl H. Cui, Gabriela Pregernig, Pamela Milani, Miriam Adam, Samuel David Perli, Samuel W. Kazer, Aleth Gaillard, Mario Hermann et al. · 2016 · Proceedings of the National Academy of Sciences
  78. CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo
    Hong Chang, Bin Yi, Ruixia Ma, Xiaoguo Zhang, Hongyou Zhao, Yaguang Xi · 2016 · Scientific Reports
  79. Regulation and Function of RNA Pseudouridylation in Human Cells
    Erin K. Borchardt, Nicole M. Martínez, Wendy V. Gilbert · 2020 · Annual Review of Genetics
  80. An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury
    Xiao‐Jing Zhang, Xu Cheng, Zhenzhen Yan, Jing Fang, Xiaozhan Wang, Weijun Wang, Zhenyu Liu, Lijun Shen, Peng Zhang, Pi‐Xiao Wang et al. · 2017 · Nature Medicine
  81. Patterns of ribosomal protein expression specify normal and malignant human cells
    Joao C. Guimaraes, Mihaela Zavolan · 2016 · Genome biology
  82. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer
    Kevin P. O’Rourke, Evangelia Loizou, Geulah Livshits, Emma M. Schatoff, Timour Baslan, Eusebio Manchado, Janelle M. Simon, Paul Bernard Romesser, Benjamin I. Leach, Teng Han et al. · 2017 · Nature Biotechnology
  83. Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
    Edward M. Kennedy, Leda Bassit, Henrik Mueller, Anand V. R. Kornepati, Hal P. Bogerd, Ting Nie, Payel Chatterjee, Hassan Javanbakht, Raymond F. Schinazi, Bryan R. Cullen · 2014 · Virology
  84. Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells
    Graham Dickson and Hugh MacLeod, Danielle Bozek, Nishani Rajakulendran, Vernon Monteiro, Moloud Ahmadi, Zachary Steinhart, Michelle M. Kushida, Helen Yu, Fiona J. Coutinho, Florence M.G. Cavalli et al. · 2018 · Cell Reports
  85. MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway
    Junhong Guan, Changzheng Lu, Qihuang Jin, Huiming Lu, Xiang Chen, Lei Tian, Yanbin Zhang, Janice Ortega, Junqiu Zhang, Silvia Siteni et al. · 2020 · Cancer Cell
  86. A prenylated dsRNA sensor protects against severe COVID-19
    Arthur Wickenhagen, Elena Sugrue, Spyros Lytras, Kuchi Srikeerthana, Marko Noerenberg, Matthew L. Turnbull, Colin Loney, Vanessa Herder, Jay Allan, Innes Jarmson et al. · 2021 · Science
  87. Exosome-mediated delivery of gene vectors for gene therapy
    Duan, Li, Xu, Limei, Xu, Xiao, Qin, Zhuan, Zhou, Xiaoying, Xiao, Yin, Liang, Yujie, Xia, Jiang · 2021 · Nanoscale
  88. High-throughput mapping of regulatory DNA
    Rajagopal, Nisha, Srinivasan, Sharanya, Kooshesh, Kameron, Guo, Yuchun, Edwards, Matthew D, Banerjee, Budhaditya, Syed, Tahin, Emons, Bart J M, Gifford, David K, Sherwood, Richard I · 2016 · Nature Biotechnology
  89. SpCas9 activity prediction by DeepSpCas9, a deep learning–based model with high generalization performance
    Hui Kwon Kim, Younggwang Kim, Sungtae Lee, Seonwoo Min, Jung Yoon Bae, Jae Woo Choi, Jinman Park, Dongmin Jung, Sungroh Yoon, Seokjoong Kim · 2019 · Science Advances
  90. A USP28–53BP1–p53–p21 signaling axis arrests growth after centrosome loss or prolonged mitosis
    Bramwell G. Lambrus, Vikas Daggubati, Yumi Uetake, Phillip M. Scott, Kevin M. Clutario, Greenfield Sluder, Andrew Jon Holland · 2016 · The Journal of Cell Biology
  91. Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9
    Peiwu Qin, Mahmut Parlak, Cem Kuscu, Jigar N. Bandaria, Mustafa Mir, Karol A. Szlachta, Ritambhara Singh, Xavier Darzacq, Ahmet Yıldız, Mazhar Adli · 2017 · Nature Communications
  92. Methods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes
    Hess, Gaelen T., Tycko, Josh, Yao, David, Bassik, Michael C. · 2017 · Molecular Cell
  93. Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies
    Devon A. Lukow, Erin L. Sausville, Pavit Suri, Narendra Kumar Chunduri, Angela Wieland, Justin Leu, Joan C. Smith, Vishruth Girish, Ankith A. Kumar, Jude Kendall et al. · 2021 · Developmental Cell
  94. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
    Xin Han, Zongbin Liu, Myeong Chan Jo, Kai Zhang, Ying Li, Zihua Zeng, Nan Li, Youli Zu, Lidong Qin · 2015 · Science Advances
  95. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
    Rhamy Zeid, Matthew A. Lawlor, Evon Poon, Jaime M. Reyes, Mariateresa Fulciniti, Michael A. Lopez, Thomas G. Scott, Behnam Nabet, Michael A. Erb, Georg E. Winter et al. · 2018 · Nature Genetics
  96. Genome-wide CRISPR-dCas9 screens in E. coli identify essential genes and phage host factors
    François Rousset, Lun Cui, Elise Siouve, Christophe Bécavin, Florence Depardieu, David Bikard · 2018 · PLoS Genetics
  97. The New State of the Art: Cas9 for Gene Activation and Repression
    Marie F. La Russa, Lei S. Qi · 2015 · Molecular and Cellular Biology
  98. Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
    Francis W. Hunter, Bradly G. Wouters, William Robert Wilson · 2016 · British Journal of Cancer
  99. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation
    Xiujing Feng, Wen Yu, Xinda Li, Feifei Zhou, Wenlong Zhang, Qi Shen, Jian‐Xin Li, Can Zhang, Pingping Shen · 2017 · Biochemical Pharmacology
  100. Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis
    Yun Liao, Junjie Zhao, Katarzyna Bulek, Fangqiang Tang, Xing Chen, Gang Cai, Shang Jia, Paul L. Fox, Emina H. Huang, Theresa T. Pizarro et al. · 2020 · Nature Communications